Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	45.83B
Revenue (ttm)	18.09B
Net Income (ttm)	1.35B
Shares Out	1.37B
EPS (ttm)	0.99
PE Ratio	33.83
Forward PE	35.55
Dividend	1.00 (2.99%)
Ex-Dividend Date	Jun 30, 2025

Volume	5,406,450
Average Volume	8,497,898
Open	33.24
Previous Close	33.25
Day's Range	32.96 - 33.42
52-Week Range	32.96 - 43.00
Beta	0.17
RSI	40.74
Earnings Date	Mar 31, 2026

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used for cardiovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive system, pediatrics, wind and dampness-removing, or...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2024, Beijing Tongrentang's revenue was 18.60 billion, an increase of 4.12% compared to the previous year's 17.86 billion. Earnings were 1.53 billion, a decrease of -8.54%.